NCT06693271

Brief Summary

Cardiovascular diseases (CVD) are a leading cause of morbidity and mortality worldwide. While CVDs are predominantly diseases of aging, age itself does not predict CVD risk; people age at different rates. Frailty is a state of accelerated aging that increases the risk of adverse health outcomes. Frail people are at higher risk of developing CVDs, experiencing complications, and dying from these diseases than fit people of the same age. Indeed, frailty predicts the likelihood of developing CVD independently of traditional risk factors for CVD. It is known that older women are frailer than men and tend to express CVDs differently than men, but whether relationships between frailty and CVD are sex specific is unclear. It is possible that shared pathophysiological mechanisms such as chronic inflammation may help explain links between CVD and frailty. Importantly, the degree of frailty can be modified by lifestyle interventions. For example, sedentary lifestyles, food insecurity, and suboptimal dietary habits can exacerbate frailty whereas diet and exercise interventions can attenuate frailty. The investigators propose that a comprehensive health strategy targeting diet and physical activity to reduce frailty will reduce the risk of cardiovascular disease (CVD), thereby promoting healthy aging. Engaging in physical activity (e.g. exercise) helps improve aerobic fitness, increase muscle mass, promote cardiac regeneration, enhance metabolic function, regulate blood pressure, improve insulin sensitivity, reduce inflammation (a key frailty mechanism), and lessen frailty. High-quality dietary protein is essential to maintain muscle mass/function, preserve mobility, attenuate inflammation, and reduce frailty. Packed with antioxidants such as anthocyanins and flavonoids, with high levels of fiber, vitamins, and minerals, blueberries, a local Nova Scotian food, can help lower blood pressure, improve blood vessel function, reduce inflammation, and help the body utilize dietary protein. These are critical aspects of a strong heart and healthy aging. To date, many frailty intervention studies have been limited by small sample sizes, underrepresentation of women, and/or by testing individual lifestyle modifications rather than synergistic effects; additionally, none have investigated how reducing frailty impacts cardiovascular outcomes. Our goal is to determine if a year-long multidomain intervention of protein, blueberries, and exercise reduces frailty and cardiovascular disease risk in older at-risk Nova Scotians of both sexes.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
240

participants targeted

Target at P75+ for not_applicable

Timeline
31mo left

Started Dec 2025

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress16%
Dec 2025Dec 2028

First Submitted

Initial submission to the registry

November 14, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

November 18, 2024

Completed
1.1 years until next milestone

Study Start

First participant enrolled

December 15, 2025

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2028

Expected
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2028

Last Updated

May 20, 2026

Status Verified

May 1, 2026

Enrollment Period

2.5 years

First QC Date

November 14, 2024

Last Update Submit

May 19, 2026

Conditions

Keywords

Cardiovascular DiseaseFrailtyBlueberriesExerciseProteinObesityHypertensionHyperlipidemiaSedentary LifestyleOlder Adults

Outcome Measures

Primary Outcomes (11)

  • Functional Fitness

    Assessed using a 6-minute walk test (6MWT). Total distance in meters will be recorded.

    Baseline, 3,6,9, and 12 months

  • Echocardiography

    Ejection fraction will be measured in M-mode and global longitudinal strain will be assessed.

    Baseline, 12 Months

  • Inflammatory Markers

    Plasma will be obtained from blood samples collected at two time points, pre- and post-intervention. A multiplex assay will be used to quantify anti-inflammatory and inflammatory cytokines in the plasma sample. The following cytokines will be quantified (pg/ml): APRIL / TNFSF13, BAFF / TNFSF13B, sCD30 / TNFRSF8, sCD163, Chitinase-3-like, gp130 / sIL-6Rβ, IFN-α2, IFN-β, IFN-γ, IL-2, sIL-6Rα, IL-8, IL-10, IL-1, IL-12 (p40), IL-12 (p70), IL-19, IL-20, IL-22, IL-26, IL-27 (p28), IL-28A / IFN-λ2, IL-29/IFN-λ1, IL-32, IL-34, IL-35, LIGHT / TNFSF14, MMP-1, MMP-2, MMP-3, Osteocalcin, Osteopontin, Pentraxin-3, sTNF-R1, sTNF-R2, TSLP, TWEAK / TNFSF12.

    Baseline, 12 Months

  • Frailty

    Frailty will be assessed using the Clinical Frailty Scale (CFS), Pictorial Fir-Frail Scale (PFFS), and Frailty Index

    Baseline, 3,6,9, and 12 months

  • Cardiovascualr Risk: Blood pressure

    Resting blood pressure (systolic/diastolic) will be assessed using an automated blood pressure cuff. Blood pressure will be measure in mm of Hg.

    Baseline, 3, 6, 9, 12 months

  • Cardiovascualr Risk: Lipid Profile

    Blood will be drawn by venipuncture and then sent to the hospital lab. There the lipid profile will be determined. Specifically, total cholesterol (mmol/L), triglycerides (mmol/L), low density lipoprotein (mmol/L) and high density lipoprotein (mmol/L) will be quantified.

    Baseline, 12 months

  • Cardiovascualr Risk: Blood glucose

    After fasting for 12 hours the participants blood will be drawn by venipuncture. Blood samples will be sent to the hospital lab and fasting glucose (mmol/L) will be assessed.

    Baseline, 12 months

  • Frailty: Clinical Frailty Scale (CFS)

    Frailty will be assessed using the CFS. The scale for the assessment ranges from 0 to 9, where 0 represents a robust individual and 9 represents terminally ill. A score of 4 or higher indicates frailty. This is a clinical judgement tool.

    Baseline, 3, 6, 9, 12 months

  • Frailty: Pictorial Fit to frail Scale (PFFS)

    Frailty will be assessed with the PFFS. The PFFS is completed by the participant and uses visual images to assess their level of fitness/frailty. There are 14 sets of images on the PFFS. Each set contains 3-4 images and the participant is asked to pick the images that represents how they "usually" feel. The questionnaire is scored out of 43, with higher scores representing a higher degree of frailty.

    Baseline, 3, 6, 9, 12 months

  • Household Foodwork Interactional Assessment 10 Questions (FIA-Q10)

    Household foodwork is "all the tasks a household does for eating". This includes the physical parts of foodwork (such as shopping, chopping, cooking, and cleaning) and the mental parts (such as budgeting, monitoring how much food is at home and what is needed, and remembering food allergies and special diets).

    Baseline, 6-month, 12-month, 1 year

  • ASA24 Dietary Assessment Tool

    Baseline, 6-month, 12-month, 1-year.

Secondary Outcomes (6)

  • Muscular Health: Lower Body Strength

    Baseline, 3,6,9, and 12 months

  • Balance

    Baseline, 3,6,9, and 12 months

  • Mobility: Lower Body

    Baseline, 3,6,9, and 12 months

  • Overall Health

    Baseline, 3,6,9, and 12 months

  • Muscular Health: Upper Body

    Baseline, 3, 6, 9, 12 months

  • +1 more secondary outcomes

Other Outcomes (2)

  • Safety Outcomes

    Safety will be assessed at 1,3,6,9, and 12 months.

  • Study Adherence

    On the last day of the month particpants will upload the months logbook. (e.g. On November 30th, participant would upload the November logbook). This will be done for every month the participant is in the study (i.e. 12 months).

Study Arms (2)

intervention of protein, blueberries, and exercise

ACTIVE COMPARATOR

treatment groups will receive the STRONG intervention of 30g/day (1 scoop) of a colorless, tasteless whey protein isolate powder supplement and 1 cup (150 grams) of blueberries per day. They will also participate in three 60-minute multimodal exercise sessions per week. Each session will include a warm-up and cool-down (\~5 minutes each), 30 minutes of moderate intensity aerobic exercise and 20 minutes of moderate intensity resistance training. The intervention lasts for 12 months.

Dietary Supplement: intervention of protein, blueberriesBehavioral: Exercise training

Control group

NO INTERVENTION

Participants receive usual standard of care.

Interventions

intervention of 30g/day (1 scoop) of a colorless, tasteless whey protein isolate powder supplement and 1 cup (150 grams) of blueberries per day.

intervention of protein, blueberries, and exercise

Three 60-minute multimodal exercise sessions per week. Exercise interventions will be individualized to each participant based on their fitness level as per recommended guidelines for older adults. Each session will include a warm-up and cool-down (\~5 minutes each), 30 minutes of moderate intensity aerobic exercise and 20 minutes of moderate intensity resistance training.

intervention of protein, blueberries, and exercise

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Must be 65 years of age or above
  • Must be willing to participate in a low to moderate exercise program

You may not qualify if:

  • Medical and cognitive conditions that prevent participation in the intervention
  • Allergies and or dislike of blueberries and/or protein powder

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

QEII Health Sciences Centre, Dickson Building

Halifax, Nova Scotia, B3H 2Y9, Canada

RECRUITING

MeSH Terms

Conditions

Cardiovascular DiseasesFrailtyMotor ActivityObesityHypertensionHyperlipidemiasSedentary Behavior

Interventions

blueberry extractExercise

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and SymptomsBehaviorOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsVascular DiseasesDyslipidemiasLipid Metabolism DisordersMetabolic Diseases

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Central Study Contacts

Scott A Grandy, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Affiliate Scientist

Study Record Dates

First Submitted

November 14, 2024

First Posted

November 18, 2024

Study Start

December 15, 2025

Primary Completion (Estimated)

June 30, 2028

Study Completion (Estimated)

December 31, 2028

Last Updated

May 20, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share

Locations